retatrutide 0.5 mg Lilly Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD ESC 2024: Retatrutide improves lipid

The interior layout lets you store multiple pen needles alongside your GLP-1 pens while keeping everything secure and accessible

Once fiber reaches the large intestine, bacteria break it down into smaller molecules

Glucagon receptor activation directly promotes hepatic fat oxidation

Method: Estimate efficacy of earlier (first add-on) AMT DR/ER use by evaluating PD diary data from pooled pivotal trials for 2 participant subgroups: 1) using levodopa monotherapy at baseline, or 2) 5 years since PD diagnosis at baseline

The most recently approved type, tirzepatide [archived link], is called a dual agonist because it mimics the effects of two gut hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)